Pediatric heart failure is a progressive and life-threatening condition that can have a high mortality rate. Fortunately, thanks to new therapies now available, many children can recover—but this condition needs early recognition and treatment.
In the Aug. 28, 2024 issue of Nature, researchers from University of California San Diego in the laboratory of Dr. Kevin King, associate professor of bioengineering and medicine, and a cardiologist at the Sulpizio Cardiovascular Center, report the discovery of a novel mechanism of cardiac inflammation that may expand therapeutic opportunities to prevent heart attacks from becoming heart failure.
Primary care providers are well positioned to address emotional eating because of their long-term relationships with patients, noted Jana DeSimone Wozniak, PhD and Hsiang Huang, MD, MPH, of Harvard Medical School and Cambridge Health Alliance in Cambridge, Massachusetts.
Cardiac physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will share new research and clinical insights at the European Society of Cardiology Congress in London Aug. 30 through Sept. 2.
The Cardiovascular Research Foundation (CRF) is pleased to announce the late-breaking clinical trials and science to be featured at TCT 2024.
When a person has chronic diabetes complications - such as heart attack, stroke and nerve damage - they are more likely to have a mental health disorder, and vice versa, according to a study. Researchers say the findings highlight a need for clinicians to actively screen for mental health disorders in patients with diabetes in addition to screening for chronic complications, which is the recommended standard of care in diabetes.
Congenital Heart Disease in Companion Animals
A new study from researchers with UCLA Health and collaborating organizations has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH).
Vanderbilt University Medical Center (VUMC) is one of roughly 60 study sites worldwide participating in RESPONDER-HF, a randomized clinical trial of an atrial shunt to treat heart failure patients.
Cleveland Clinic researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease.
Investigators with the Smidt Heart Institute at Cedars-Sinai have developed an artificial intelligence (AI) program to detect the presence and severity of mitral valve regurgitation, the most common heart valve disorder.
A team led by a Children’s Hospital Los Angeles heart surgeon has received a patent for a novel device design that could solve a pressing problem: how to bridge patients with a Fontan circulation to heart transplant.
Heart failure is especially fatal for people without access to medical facilities. A research team aims to bring heart failure screening from the lab to the home with a biosensor that uses a drop of saliva to screen for biomarkers of the disease. They will present their results at ACS Fall 2024.
Children born with certain heart defects receive a shunt implant to improve blood flow. The shunt must be replaced as their bodies grow. Researchers say a new light-reactive expandable shunt could cut the number of surgeries these children receive. They will present their results at ACS Fall 2024.
En el calor abrasador del verano, cualquier persona que pase tiempo afuera podría beneficiarse de un tejido refrigerante. Pero ahora, los investigadores han innovado con un revestimiento de microescala a base de tiza que enfría el aire debajo del tejido tratado hasta 13 grados Celsius. Presentarán sus resultados en la ACS Fall 2024.
Los niños que nacen con ciertos defectos cardíacos se someten a un implante de shunt para mejorar el flujo sanguíneo. El shunt debe cambiarse a medida que el cuerpo crece. Los investigadores informan que un nuevo shunt expandible que reacciona a la luz podría reducir el número de cirugías a las que se someten estos niños. Presentarán sus resultados en la ACS Fall 2024.
Taghreed Mohammed Al-Turki, PhD, a postdoctoral researcher in the UNC Lineberger lab of Jack Griffith, PhD, describes her long, difficult, and rewarding journey of becoming a telomere scientist as a first-time mother at the University of North Carolina School of Medicine.
New Cleveland Clinic and Tufts University research shows that elevated levels of the gut microbiome trimethylamine N-oxide (TMAO) pathway led to a higher risk of heart failure independent of other risk factors, according to a study of two large National Institutes of Health cohorts. The study was recently published in the journal Circulation: Heart Failure.
The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and published in JAMA Cardiology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
